INS and type 2 diabetes mellitus: Studies have shown that the metabolic regulation signaling pathway of insulin in obesity and T2DM is blocked; however, the signaling pathway that promotes proliferation is not blocked, which may lead to atherosclerosis and various microvascular complications (32).